Document Detail


Ivermectin is better than benzyl benzoate for childhood scabies in developing countries.
MedLine Citation:
PMID:  12174005     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To compare single dose oral ivermectin with topical benzyl benzoate for the treatment of paediatric scabies. METHODS: An observer-blinded randomized controlled trial was undertaken at Vila Central Hospital, Vanuatu. One hundred and ten children aged from 6 months to 14 years were randomized to receive either ivermectin 200 micro g/kg orally or 10% benzyl benzoate topically. Follow up was at 3 weeks post-treatment. Primary outcome measures were the number of scabies lesions, the itch visual analogue score and nocturnal itch. Secondary outcome measures were the skin's reaction to treatment, the passage of worms in stool and other side effects. RESULTS: Eighty patients completed the study protocol. There was no significant difference between the two treatments; both produced a significant decrease in the number of scabies lesions seen at follow up. Ivermectin cured 24 out of 43 patients (56%), and benzyl benzoate 19 out of 37 patients (51%) at 3 weeks post-treatment. No serious side effects were noted with either treatment, but benzyl benzoate was more likely to produce local skin reactions (P = 0.004, OR 6.4, 95% CI 1.6-25.0) CONCLUSIONS: Ivermectin is cheap and effective in the treatment of paediatric scabies. Ivermectin has minimal observed toxicity and has the additional beneficial effects of antiparasitic action in onchocerciasis, filariasis and strongyloidiasis. Ivermectin is better than benzyl benzoate for the treatment of paediatric scabies in developing countries.
Authors:
P A Brooks; R F Grace
Related Documents :
16167415 - The role of number of treatments in laser-assisted hair removal using a 755-nm alexandr...
16213985 - A new option in the treatment of skin tears for the institutionalized resident: formula...
17214675 - Fractional photothermolysis: treatment of facial and nonfacial cutaneous photodamage wi...
17543155 - A pilot study of mycophenolate mofetil combined to intravenous methylprednisolone pulse...
8774645 - Peripheral infusion ports for central venous access in patients with gynecologic malign...
15517665 - Suburethral tape via the obturator route: is the tot a simplification of the tvt?
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Journal of paediatrics and child health     Volume:  38     ISSN:  1034-4810     ISO Abbreviation:  J Paediatr Child Health     Publication Date:  2002 Aug 
Date Detail:
Created Date:  2002-08-13     Completed Date:  2002-10-16     Revised Date:  2007-09-24    
Medline Journal Info:
Nlm Unique ID:  9005421     Medline TA:  J Paediatr Child Health     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  401-4     Citation Subset:  IM    
Affiliation:
Outpatients Department, Vila Central Hospital, Port Vila, Vanuatu. pdbrooks@netscape.net.au
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Benzoates / adverse effects,  economics,  therapeutic use*
Child
Child, Preschool
Cost-Benefit Analysis
Developing Countries
Double-Blind Method
Humans
Infant
Insecticides / adverse effects,  economics,  therapeutic use*
Ivermectin / adverse effects,  economics,  therapeutic use*
Scabies / drug therapy*
Vanuatu
Chemical
Reg. No./Substance:
0/Benzoates; 0/Insecticides; 120-51-4/benzyl benzoate; 70288-86-7/Ivermectin
Comments/Corrections
Comment In:
J Paediatr Child Health. 2003 Jul;39(5):392-3   [PMID:  12887676 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Incidence of alveolar capillary dysplasia in severe idiopathic persistent pulmonary hypertension of ...
Next Document:  A child with Miller Fisher syndrome.